Metabolically stable inhibitor of anandamide cellular uptake (Ki
= 3 μ
M). Displays relatively low affinity for CB1
values are 5.1 and > 10 μ
M) and for vanilloid VR1 receptors (EC50
= 10 μ
M). Has minimal activity against FAAH (Ki
> 50 μ
M). Active in vivo
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Novel selective and metabolically stable inhibitors of anandamide cellular uptake.
Ortar et al.
In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake.
de Lago et al.
The citations listed below are publications that use Tocris products. Selected citations for OMDM-2 include:
Showing Results 1 - 1 of 1